Study shows how thymoglobulin reduces rejection risk in kidney transplantTelemanagementThe two most common antibodies used are thymoglobulin and basiliximab. In a new trial carried out by researchers at Washington University School of Medicine the two …

Epilepsy Research UKImproving seizure control in tuberous sclerosisEpilepsy Research UKA drug known as everolimus, which was originally developed to prevent rejection following organ transplantation, has shown effectiveness in the treatment of many asp…

Frontline Sunitinib Compared to Everolimus in mRCCOncLive… favorable or intermediate prognoses. Overall, the trial did not demonstrate that first-line everolimus was noninferior to first-line sunitinib, further solidifying sunitinib as the preferred …

Medical DailyNovartis phase III study of Afinitor in advanced liver cancer fails to meet …pharmabiz.comNovartis announced that results of a global phase III study showed that Afinitor (everolimus) did not extend overall survival compared to placebo i…

Meta-analysis makes case for drug-eluting stents in STEMITheHeart.OrgNew York, NY – Newer-generation drug-eluting stents, particularly the everolimus-eluting stent (Xience V, Abbot; Promus, Boston Scientific), significantly reduce the risk of target ve…

House bill looks to extend Medicare coverage of immunosuppressive drugs for …OregonLive.comFrom a brother-to-brother kidney donation, the gift of life With the waiting list for kidneys growing longer as donations fall, a living kidney donation can be…

MedscapeEverolimus: A Novel Treatment for Seizures?MedscapeThe immunosuppressant/anticancer agent everolimus was associated with a dramatic reduction in seizures in patients with tuberous sclerosis complex in whom treatment with many other antiepilepti…